Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Sponsorship

Advertise with PSA

Reach readers who follow psychedelic policy, science and business.

  • Newsletter post sponsorship

    One labelled sponsor block per post

  • Website sponsor slot

    Matched to a desk, shown after the story’s ranked widgets

  • Event sponsorship

    Mixers and live shows

Advertisers, sponsors, donors and partners never pay for, review or shape our coverage. Every ad, sponsorship and partner piece is clearly labelled and kept separate from our reporting. How PSA is funded →